2012
DOI: 10.1136/gutjnl-2011-301746
|View full text |Cite
|
Sign up to set email alerts
|

Treatment of pancreatic fibrosis with siRNA against a collagen-specific chaperone in vitamin A-coupled liposomes

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
48
0

Year Published

2014
2014
2023
2023

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 65 publications
(48 citation statements)
references
References 25 publications
0
48
0
Order By: Relevance
“…Recent studies have demonstrated that the therapeutic resistance of PDAC can be overcome by combining classical chemotherapy with matrix-degrading approaches, such as enzymatic degradation of hyaluronic acid (8,36), drug stabilization and stromal depletion by nab-paclitaxel (6,37) or the hedgehog signaling inhibitor IPI-926 (7,38), or siRNA-mediated targeting of a collagen type I-specific chaperone in PSCs (39). A phase II clinical trial has already demonstrated beneficial effects of combinatorial therapy with gemcitabine and nab-paclitaxel on the survival of patients with pancreatic cancer (37).…”
Section: Discussionmentioning
confidence: 99%
“…Recent studies have demonstrated that the therapeutic resistance of PDAC can be overcome by combining classical chemotherapy with matrix-degrading approaches, such as enzymatic degradation of hyaluronic acid (8,36), drug stabilization and stromal depletion by nab-paclitaxel (6,37) or the hedgehog signaling inhibitor IPI-926 (7,38), or siRNA-mediated targeting of a collagen type I-specific chaperone in PSCs (39). A phase II clinical trial has already demonstrated beneficial effects of combinatorial therapy with gemcitabine and nab-paclitaxel on the survival of patients with pancreatic cancer (37).…”
Section: Discussionmentioning
confidence: 99%
“…This correlational expression of Hsp47 and collagens is important for the potential treatment of fibrotic disorders because down-regulation of Hsp47 expression by RNAi or antisense RNA methods markedly delays the progression of fibrosis and concomitantly reduces the level of collagen in the extracellular matrix (27)(28)(29)(30)(31). Recently, knockdown of Hsp47 in the HSCs of rat, which was achieved using a drug delivery system to target RNAi specifically to these cells, was shown to markedly prevent the progression of experimental liver fibrosis (28,30). In this report, apoptotic death of HSCs in rats treated with Hsp47-targeting RNAi was suggested to be a major reason underlying the dramatic therapeutic effects on liver fibrosis.…”
Section: Discussionmentioning
confidence: 99%
“…Therefore, the induction of the death of activated HSCs by suppression of Hsp47 expression may be an attractive therapeutic strategy for liver fibrosis. Actually, suppression of Hsp47 expression was reported to attenuate liver fibrosis via inducing the apoptosis of HSCs (28,30); however, the reason why apoptosis is induced upon suppression of Hsp47 expression remains unknown. We previously reported that ER stress causes apoptotic cell death with the induction of CHOP expression in Hsp47-disrupted mice and cells (18,20,22).…”
mentioning
confidence: 99%
See 1 more Smart Citation
“…26 The DBTC solution was administered into the left jugular vein with a syringe at 5 mg/kg body weight, according to a previous report. 27 In the control group, one volume of solvent …”
Section: Induction Of Chronic Pancreatitis and Human Amsc Transplantamentioning
confidence: 99%